Low molecular weight (LMW) GTP-binding proteins, including ADP-ribosylation factors (ARFs, cofactors for in vitro cholera toxin-catalyzed ADP- ribosylation), are localized in the protein secretory pathway and are thought to function by cycling between cytosol and membranes. Although purified predominately as a cytosolic protein, ARF associates with membrane fractions in the presence of non-hydrolyzable GTP-analogues. Fatty acylation of LMW GTP-binding proteins has been shown to be important for membrane attachment. In contrast to other LMW GTP-binding proteins (e.g., ras), which are post-translationally modified at their C-termini (e.g., polyisoprenylation, palmitoylation), ARF is co-translationally myristoylated at its N-terminus. We hypothesized that N-terminal myristoylation of ARF, as shown for pp60v-src, may be important for membrane attachment. To investigate the role of N-terminal myristoylation, recombinant ARF was expressed in a bacterial expression system which lacks the enzymatic activity necessary for myristoylation. Myristoylated ARF was prepared by co-expression with the gene encoding yeast myristoly- CoA:protein N-myristoyltransferase (NMT). Analysis of the recombinant ARFs (myristoylated and non-myristoylated) indicated that the recombinant proteins exhibited similar biochemical activity as measured by GTP displacement and in vitro activation of cholera toxin-catalyzed ADP- ribosylagmatine formation. In an in vitro translocation assay, however, myristoylated ARF 5 demonstrated a temperature- and GTP-dependent association with Golgi, whereas non-myristoylated ARF did not translocate to Golgi under any of the experimental conditions. In addition, using three different concentrations of Golgi, myristoylated ARF 5 displayed saturable binding to the Golgi suggesting that it interacts with a specific protein target. These data indicate that myristoylation is necessary, though not sufficient, for membrane attachment and are consistent with a function in which ARF cycles between soluble and membrane compartments in vivo.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Intramural Research (Z01)
Project #
1Z01HL000657-02
Application #
3843270
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code